MedPath

Fatigue Reduction in Chronic Kidney Disease (CKD)

Not Applicable
Recruiting
Conditions
Chronic Kidney Diseases
Fatigue
Registration Number
NCT06768983
Lead Sponsor
NYU Langone Health
Brief Summary

In this pilot trial, investigators will pilot test a cognitive behavioral intervention for acceptability and proof of concept for a larger future trial to be submitted for federal funding. This is a one-group design with qualitative and quantitative data collection integrated into the intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Interest in participating in a fatigue study
  • Age ≥18 years old
  • Estimated glomerular filtration rate (eGFR) 15-44 mL/min/1.73 m2
  • Ability and willingness to provide informed consent
  • Ability to speak English
  • Ability to walk
  • Ability to join remote study sessions via WebEx
Exclusion Criteria
  • Current involvement in an activity/exercise program
  • High likelihood of a kidney transplant within 6 months (assessed via the medical record)
  • Any safety concerns about increased walking (assessed via the medical record)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Session AdherenceUp to Week 12

Measure of feasibility; calculated as the percentage of planned sessions that were actually attended by participants.

Secondary Outcome Measures
NameTimeMethod
Change in Functional Assessment of Chronic Illness Therapy (FACIT) - Fatigue ScoreBaseline, Week 12

The FACIT Measurement System is a collection of health-related quality of life (HRQOL) questionnaires targeted to the management of chronic illness. The Fatigue Subscale comprises 13 items and measures symptoms of fatigue. Each item is rated on a scale from 0 (not at all) to 4 (very much); the total score is the sum of responses and ranges from from 0 to 52; lower scores indicate greater fatigue.

Change in Dialysis Symptom Index (DSI) ScoreBaseline, Week 12

The DSI is 30-item assessment of CKD-related unpleasant symptoms. Each item is rated on a scale from 0 (not at all) to 4 (very much). The total score is the sum of the responses, ranging from 0 to 120. A higher score indicates a greater symptom burden.

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath